Should You Buy Rocket Lab While It's Below $27?

In This Article:

Key Points

  • Rocket Lab stock sold off after earnings this month, but quickly bounced back.

  • At $26 a share or so, the stock has momentum from press releases -- but costs significantly more than it did before missing earnings.

  • Rocket Lab stock could go on sale soon, if forced to delay its upcoming Neutron rocket launch.

  • 10 stocks we like better than Rocket Lab USA ›

Rocket Lab (NASDAQ: RKLB) is on a roll.

Recovering quickly from its first-quarter earnings miss earlier this month, shares of the manufacturer of small satellites and the small rockets to launch them zoomed higher after the company issued a series of press releases. Among other things, Rocket Lab has announced:

  • A contract to experiment with point-to-point cargo transportation by rocket for the U.S. Air Force Research Laboratory (AFRL).

  • A NASA contract to launch the Aspera spacecraft to "study the formation and evolution of galaxies and provide new insights into how the universe works."

  • Another successful synthetic aperture radar (SAR) launch for Japan's Institute for Q-shu Pioneers of Space, Inc. (iQPS).

  • And a third launch and recovery of a W-class space capsule for "orbital pharmaceuticals" company Varda Space Industries.

At a price just under $26 today, Rocket Lab stock has now bounced back so high that it costs 9% more than it did before the earnings miss on May 8. But the stock's also still 20% below an intraday high set back in January. With momentum seemingly firmly on its side, investors may now be wondering: Should you buy Rocket Lab stock here at $26, before it rockets even higher?

And the answer is a definite maybe. (Although I'm leaning toward no.)

A rocket clearing a cloudbank and shooting into space.
Image source: Getty Images.

The biggest reason not to buy Rocket Lab stock

Don't get me wrong. I happen to think Rocket Lab is a great company, and with great long-term prospects. I just don't think you should overpay to own a piece of those prospects.

If you look out five years, analysts polled by S&P Global Market Intelligence anticipate that Rocket Lab will grow into a solidly profitable company, doing $3.5 billion in annual revenue, and translating $1.1 billion of that revenue into real profit according to generally accepted accounting principles (GAAP). Viewed from this perspective, Rocket Lab stock that costs $12 billion today (or just under $26 per share) looks pretty attractive, costing just 11 times earnings.

The problem is, these are forward earnings. Very forward earnings. And they might not arrive either in the quantity, or according to the time frame, that analysts predict. (Case in point: In 2022, these same analysts were forecasting Rocket Lab would earn its first profit in 2025. But three years later, opinions have changed -- and Rocket Lab is forecast to lose $193 million this year.)